U.S. flag

An official website of the United States government

NM_001008216.2(GALE):c.956G>A (p.Gly319Glu) AND not provided

Germline classification:
Uncertain significance; other (4 submissions)
Last evaluated:
Jun 21, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000078697.26

Allele description [Variation Report for NM_001008216.2(GALE):c.956G>A (p.Gly319Glu)]

NM_001008216.2(GALE):c.956G>A (p.Gly319Glu)

Gene:
GALE:UDP-galactose-4-epimerase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.11
Genomic location:
Preferred name:
NM_001008216.2(GALE):c.956G>A (p.Gly319Glu)
HGVS:
  • NC_000001.11:g.23796183C>T
  • NG_007068.1:g.9622G>A
  • NM_000403.4:c.956G>A
  • NM_001008216.2:c.956G>AMANE SELECT
  • NM_001127621.2:c.956G>A
  • NP_000394.2:p.Gly319Glu
  • NP_000394.2:p.Gly319Glu
  • NP_001008217.1:p.Gly319Glu
  • NP_001121093.1:p.Gly319Glu
  • NC_000001.10:g.24122673C>T
  • NM_000403.3:c.956G>A
  • Q14376:p.Gly319Glu
Protein change:
G319E; GLY319GLU
Links:
UniProtKB: Q14376#VAR_002546; OMIM: 606953.0007; dbSNP: rs28940885
NCBI 1000 Genomes Browser:
rs28940885
Molecular consequence:
  • NM_000403.4:c.956G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001008216.2:c.956G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127621.2:c.956G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
16

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000110557Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL ClinVar v180209 classification definitions)
other
(Jun 7, 2018)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV001468004Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Oct 19, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005410412Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 26, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV005439257GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Jun 21, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown16not providednot providednot providednot providedclinical testing

Citations

PubMed

Functional characterization of the K257R and G319E-hGALE alleles found in patients with ostensibly peripheral epimerase deficiency galactosemia.

Wasilenko J, Lucas ME, Thoden JB, Holden HM, Fridovich-Keil JL.

Mol Genet Metab. 2005 Jan;84(1):32-8.

PubMed [citation]
PMID:
15639193

Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase.

Timson DJ.

FEBS J. 2005 Dec;272(23):6170-7.

PubMed [citation]
PMID:
16302980
See all PubMed Citations (6)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000110557.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided15not providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided15not providednot providednot provided

From Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center, SCV001468004.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

PS3, BS2

Description

PS3_Supporting, BA1, PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV005410412.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (6)

Description

BS1, BS3, PP3, PP4

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From GeneDx, SCV005439257.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16302980, 18188677, 30409984, 15639193, 22995991, 9538513, 23644136, 16385452)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 13, 2025